Harrington Group Limited
News
Harrington Group (ASX: HGR) advises that having completed the necessary studies the Company's subsidiary Sun Biomedical Laboratories (SBL) has filed for US Food and Drug Administration (FDA) 510(k) clearance for the Company's saliva illicit drug screening device OraLine.
###
2,814 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 30 Days: 4) (Since Published: 2814)
